Coalitions and Compliance: The Political Economy of Pharmaceutical Patents in Latin America

Since the late 1980s developing countries have come under considerable pressure to revise their intellectual property policies and practices. One area where pressures have been exceptionally controversial is in pharmaceuticals: historically, fearing the costs of providing private property rights over knowledge in this area, developing countries did not grant patents to drugs. Now they must do so.